atipamezole
| SMILES | CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 |
| InChIKey | HSWPZIDYAHLZDD-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 1 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 2 |
| Molecular weight (Da) | 212.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
| Ligand site mutations | α2A |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.5 | 8.5 | 8.5 | Guide to Pharmacology |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.9 | 7.9 | 7.9 | Guide to Pharmacology |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.5 | 8.5 | 8.5 | Guide to Pharmacology |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.5 | 8.72 | 8.92 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 9.48 | 9.48 | 9.48 | PDSP Ki database |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 9.34 | 9.34 | 9.34 | PDSP Ki database |
| α2C | ADA2C | North American opossum | Adrenoceptors | A | pKi | 8.56 | 8.56 | 8.56 | PDSP Ki database |
| α2B | ADA2B | Rat | Adrenoceptors | A | pKi | 9.17 | 9.17 | 9.17 | PDSP Ki database |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 5.71 | 5.71 | 5.71 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.65 | 8.65 | 8.65 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.38 | 8.38 | 8.38 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |